Oramed Pharmaceuticals Inc. (ORMP) on Monday reported earnings of $78.2 million in its second quarter. The New York-based company said it had net income of $1.84 per share. Losses, adjusted for non-recurring gains, were 9 cents per share.
Original reporting: Alexandria, VA News – WTOP News — read the source article.